Advertisement
U.S. Markets close in 43 mins

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
24.66+0.22 (+0.90%)
As of 03:14PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close24.44
Open24.48
Bid0.00 x 0
Ask0.00 x 0
Day's Range24.43 - 24.92
52 Week Range18.08 - 29.12
Volume35,650
Avg. Volume48,893
Market Cap364.887M
Beta (5Y Monthly)0.83
PE Ratio (TTM)N/A
EPS (TTM)-5.06
Earnings DateOct 31, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est34.50
  • GlobeNewswire

    Anika Announces Third Quarter 2024 Results Conference Call Date

    BEDFORD, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its third quarter 2024 financial results before the opening of the market on Thursday, October 31, 2024, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights. The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (in

  • GuruFocus.com

    Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

    Anika Therapeutics Inc (ANIK) reports mixed results with a focus on international expansion and new product launches to offset domestic market headwinds.